AF
IDYA icon

Allworth Financial’s IDEAYA Biosciences IDYA Stock Holding History

Allworth Financial’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Sell
451
-8
-2% -$245 ﹤0.01% 3334
2026
Q1 		$15.3K Buy
459
+39
+9% +$1.31K ﹤0.01% 3186
2025
Q4 		$14.5K Sell
420
-94
-18% -$3K ﹤0.01% 3013
2025
Q3 		$14K Buy
514
+152
+42% +$3.68K ﹤0.01% 2924
2025
Q2 		$7.61K Buy
362
+136
+60% +$2.61K ﹤0.01% 3032
2025
Q1 		$4.31K Buy
226
+115
+104% +$2.45K ﹤0.01% 2848
2024
Q4 		$2.57K Sell
111
-789
-88% -$22.3K ﹤0.01% 3064
2024
Q3 		$28.5K Buy
900
+800
+800% +$30.3K ﹤0.01% 1690
2024
Q2 		$4.09K Hold
100
– – ﹤0.01% 2601
2024
Q1 		$4.39K Sell
100
-27
-21% -$1.16K ﹤0.01% 2456
2023
Q4 		$4.52K Hold
127
– – ﹤0.01% 2314
2023
Q3 		$3.43K Hold
127
– – ﹤0.01% 2297
2023
Q2 		$2.98K Hold
127
– – ﹤0.01% 2317
2023
Q1 		$1.74K Buy
127
+60
+90% +$1K ﹤0.01% 2463
2022
Q4 		$1.22K Buy
+67
New +$1.13K ﹤0.01% 2409

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Allworth Financial's IDYA Position: Q2 2026 in Review

Allworth Financial reduced its IDEAYA Biosciences (IDYA) stake by 1.7% in Q2 2026, selling an estimated $245 and leaving 451 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3334.

Allworth Financial first reported a position in IDYA in Q4 2022 and has held it in 15 quarters since. The position peaked at $28.5K in Q3 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Allworth Financial held 451 shares of IDEAYA Biosciences worth $16.8K as of Q2 2026.
  • Allworth Financial sold 8 IDEAYA Biosciences shares in Q2 2026, an estimated $245.
  • IDEAYA Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3334 holding.
  • Allworth Financial first reported a position in IDEAYA Biosciences in Q4 2022 and has held it in 15 quarters since.
  • Allworth Financial's IDEAYA Biosciences position peaked at $28.5K in Q3 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.